Skip to main content

Advertisement

SpringerLink
Log in

Adiponectin incompletely prevent MCP-1-dependent restenosis after percutaneous coronary intervension in patients with coronary artery disease

  • Published:
Journal of Thrombosis and Thrombolysis Aims and scope Submit manuscript

Abstract

Background

Some factors play pathogenic roles in the development of restenosis after percutaneous coronary intervention (PCI). We measured and compared the ratio of elevated levels of monocytic chemotactic peptide-1 (MCP-1), regulated on activation normally T-cell expressed and secreted (RANTES), soluble (s) P-selectin, sE-selectin and adiponectin after PCI.

Methods

Plasma levels of chemokines and soluble markers were measured before and 30 days after PCI in 96 patients (69 males and 27 females, aged 63 ± 9 years) who underwent PCI and who had repeated angiograms at a 6-month follow-up. In addition, we carried out the basic study of the tissue factor expression on monocytic cell line (THP-1) by MCP-1.

Results

Restenosis occurred in 33 (34.4%) patients. A significant and time-dependent increase in MCP-1 was observed in the restenosis group. However, there were no significant differences in RANTES, sP-selectin, and sE-selectin levels with or without restenosis. Adiponectin levels in patients with coronary artery disease were significantly lower than levels in normal controls. However, adiponectin levels were no different at baseline between patients with or without restenosis. MCP-1 did not induce the expression of tissue factor on THP-1. However, the recombinant sCD40 ligand-induced expression of tissue factor on THP-1 was enhanced by the addition of MCP-1.

Conclusion

These findings suggest that restenosis development after PCI in patients with coronary artery disease may involve the participation of MCP-1 after PCI, and adiponectin incompletely prevent this MCP-1-dependent restenosis.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Smith SC, Dove JT, Jacobs AK et al (2001) ACC/AHA Guidelines for percutaneous coronary intervention (revision of the 1993 PTCA guidelines)––executive summary. Circulation 103:3019–3041

    PubMed  Google Scholar 

  2. Califf RN, Fortin DF, Frid DJ et al (1991) Restenosis after coronary angioplasty: an overview. J Am Coll Cardiol 17:2B–13B

    Article  PubMed  CAS  Google Scholar 

  3. Fitzgerald DJ, Roy I, Catella F, FitzGerald GA (1986) Platelet activation in unstable angina. N Engl J Med 315:983–989

    Article  PubMed  CAS  Google Scholar 

  4. Liu M, Roubin G, King S (1989) Restenosis after coronary angioplasty: Potential biologic determinants and role of intimal hyperplasia. Circulation 79:1374–1387

    PubMed  CAS  Google Scholar 

  5. Ross R (1999) Atherosclerosis––an inflammatory disease. N Engl J Med 340:115–126

    Article  PubMed  CAS  Google Scholar 

  6. Nelken N, Coughlin S, Gordon D, Wilcox JN (1991) Monocyte chemoattractant protein-1 in human atheromatous plaques. J Clin Invest 88:1121–1127

    Article  PubMed  CAS  Google Scholar 

  7. Yla-Herttuala S, Lipton B, Rosenfeld M et al (1991) Expression of monocyte chemoattractant protein-1 in macrophage-rish areas of human and rabbit atherosclerotic lesions. Proc Natl Acad Sci 80:5252–5256

    Article  Google Scholar 

  8. Reckless J, Rubin E, Verstuyft J, Metcalfe JC, Grainger DJ (1999) Monocyte chemoattractant protein-1, but not tumor necrosis factor is correlated with monocyte infiltation in mouse lipid lesions. Circulation 99:2310–2316

    PubMed  CAS  Google Scholar 

  9. Cipollone F, Marini M, Fazia M et al (2001) Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioacler Thromb Vasc Biol 21:327–334

    CAS  Google Scholar 

  10. Maeda K, Okubo K, Shimomura I et al (1996) cDNA cloning and expression of a novel adipose specific collgen-like factor, apM1 (AdiPose Most abundant Gene transcript 1). Biochem Biophys Res Commun 221:286–289

    Article  PubMed  CAS  Google Scholar 

  11. Ouchi N, Kihara S, Arita Y et al (1999) Novel modulator for endothelial adhesion molecules; adipocyte-derived plasma protein adiponectin. Circulation 100:2473–2476

    PubMed  CAS  Google Scholar 

  12. Ouchi N, Kihara S, Arita Y et al (2000) Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-B signaling through a camp-dependent pathway. Circulation 102:1296–1301

    PubMed  CAS  Google Scholar 

  13. Ouchi N, Kihara S, Arita Y et al (2001) Adipocyte-derived plasma protein, adiponectin, suppresses lipid accumulation and class A scavenger receptor expression in human monocyte-derived macropages. Circulation 103:1057–1063

    PubMed  CAS  Google Scholar 

  14. Okamoto Y, Arita Y, Nishida M et al (2000) An adipocyte-derived plasma protein, adiponectin, adheres to injured vascular walls. Horm Metab Res 32:47–50

    Article  PubMed  CAS  Google Scholar 

  15. Arita Y, Kihara S, Ouchi N et al (2002) Adipocyte-derived plasma protein adiponectin acts a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105:2893–2898

    Article  PubMed  CAS  Google Scholar 

  16. Rollins BJ (1996) Monocyte chemoattractant protein-1: a potent regulator of monocyte recruitment in inflammatory disease. Mol Med Today 2:198–204

    Article  PubMed  CAS  Google Scholar 

  17. Carr MW, Roth SJ, Luther E, Rose SS, Springer TA (1994) Monocyte chemoattractant protein-1 acts as a T-lymphocyte chemoattractant. Proc Natl Acad Sci 91:3652–3656

    Article  PubMed  CAS  Google Scholar 

  18. Aukrust P, Ueland T, Muller F et al (1998) Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation 97:1136–1143

    PubMed  CAS  Google Scholar 

  19. Conti P, Pang X, Boucher W, Letourneau R, Reale M (1997) Impact of RANTES and MCP-1 chemokines on in vivo mast cell recruitment in rat skin injection model and their role in modifying the protein and mRNA levels for histidine decarboxylase. Blood 89:4120–4127

    PubMed  CAS  Google Scholar 

  20. Ueda A, Okuda K, Ohno S et al (1994) NF-kB and Splregulate transcription of the human monocyte chemoattractant protein-1 gene. J Immunol 153:2052–2063

    PubMed  CAS  Google Scholar 

  21. Taubman MB, Rollins BJ, Poon M et al (1992) mRNA accumulates rapidly in aortic injury and in platelet-derived growth factor-stimulated vascular smooth muscle cells. Cir Res 70:314–325

    CAS  Google Scholar 

  22. Martinovic I, Abegunewardene N, Seul M et al (2005) Elevated monocyte chemoattractant protein-1 serum levels in patients at risk for coronary artery disease. Cir J 69:1484–1489

    Article  CAS  Google Scholar 

  23. Arita Y, Kihara S, Ouchi N et al (1999) Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity. Biochem Biophys Res Commun 257:79–83

    Article  PubMed  CAS  Google Scholar 

  24. Hotta K, Funahashi T, Arita Y et al (2000) Plasma concentrations of a novel adipo-specific protein, adiponectin, in type 2 diabetic patients. Arterioscler Thromb Vasc Biol 20:1595–1599

    PubMed  CAS  Google Scholar 

  25. Matsuda M, Shimomura I, Sata M et al (2002) Role of adiponectin in preventing vascular stenosis—the missing link of adipo-vascular axis. J Biol Chem 277:37487–37491

    Article  PubMed  CAS  Google Scholar 

  26. Kojima S, Funahashi T, Sakamoto T et al (2003) The variation of plasma concentrations of a novel, adipocyte derived protein, adiponectin, in patients with acute myocardial infarction. Heart 89:667

    Article  PubMed  CAS  Google Scholar 

  27. Nakamura Y, Shimada K, Fukuda D et al (2004) Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart 90:528–533

    Article  PubMed  CAS  Google Scholar 

  28. Stejskal D, Bartek J (2003) Adiponectin in patients with various stages of coronary heart disease––comparison of its concentration in coronary arteries and peripheral venous circulation. Biomed Pap Med Fuc Univ Palacky Ulomouc Czech Repub 147:161–166

    CAS  Google Scholar 

  29. Olijhoek JK, Koerselman J, de Jaegere KPPTh et al (2005) Presence of the metabolic syndrome does not impair coronary collateral vessel formation in patients with documented coronary artery disease. Diabetes Care 28:683–689

    Article  PubMed  Google Scholar 

  30. Charo IF, Taubman MB (2004) Chemokines in the pathogenesis of vascular disease. Circ Res 95:858–866

    Article  PubMed  CAS  Google Scholar 

  31. Sakamoto T, Ishibashi T, Sakamoto N et al (2005) Endogeneous NO blockade enhances tissue factor expression via increased Ca2+ influx through MCP-1 in endothelial cells by monocyte adhesion. Artherioscler Thromb Vasc Biol 25:2005–2011

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Second Department of Internal Medicine, Kansai Medical University, Moriguchi, Osaka, Japan

    Norihito Inami, Takayuki Shimazu, Kenichi Manabe, Yutaka Kimura & Toshiji Iwasaka

  2. Division of Hematology, Kishiwada City Hospital, 1001 Gakuhara-cho, Kishiwada, Osaka, 596-8501, Japan

    Shosaku Nomura

Authors
  1. Norihito Inami
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Shosaku Nomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Takayuki Shimazu
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Kenichi Manabe
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yutaka Kimura
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Toshiji Iwasaka
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Shosaku Nomura.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Inami, N., Nomura, S., Shimazu, T. et al. Adiponectin incompletely prevent MCP-1-dependent restenosis after percutaneous coronary intervension in patients with coronary artery disease. J Thromb Thrombolysis 24, 267–273 (2007). https://doi.org/10.1007/s11239-007-0042-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11239-007-0042-8

Keywords

Search

Navigation